Literature DB >> 24374016

Multiple interactive factors in hepatocarcinogenesis.

Jin Ding1, Hongyang Wang2.   

Abstract

Hepatocellular carcinoma (HCC) is the fifth most prevalent cancer and the third most frequent cause of cancer mortality globally. Each year there are approximately 630,000 new cases of HCC in the world and more than half of the new cases occur in China. Major risk factors of HCC include HBV or HCV infection, alcoholic liver disease, and nonalcoholic fatty liver disease. Most of these risk factors lead to chronic hepatitis and cirrhosis, which is present in 80-90% of HCC patients. Hepatocarcinogenesis has been regarded as a multi-stage process involving multiple genetic or environmental factors. Interaction and cross-regulation of distinct factors synergistically contributes to HCC occurrence. A comprehensive knowledge on the multiple factors and their interaction in hepatocarcinogenesis is necessary to improve the effectiveness of HCC intervention. In this review, we will focus on the recent progress made in understanding the mechanisms of hepatocarcinogenesis and discuss some potential issues or challenges in this area.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Hepatitis virus; Hepatocarcinogenesis; Inflammation; Liver tumor initiating cell

Mesh:

Year:  2013        PMID: 24374016     DOI: 10.1016/j.canlet.2013.12.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway.

Authors:  Benting Ma; Junjie Zhu; Juan Tan; Yulei Mao; Lingyun Tang; Chunling Shen; Hongxing Zhang; Ying Kuang; Jian Fei; Xiao Yang; Zhugang Wang
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 2.  p53 in liver pathologies-taking the good with the bad.

Authors:  Meital Charni; Noa Rivlin; Alina Molchadsky; Ronit Aloni-Grinstein; Varda Rotter
Journal:  J Mol Med (Berl)       Date:  2014-11-19       Impact factor: 4.599

3.  A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.

Authors:  Qiushi Tang; Ying Zhao; Yulin Wang; Minjie Wei
Journal:  Med Oncol       Date:  2014-10-01       Impact factor: 3.064

4.  A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.

Authors:  Timothy R Morgan; Kathryn Osann; Teodoro Bottiglieri; Neville Pimstone; John C Hoefs; Ke-Qin Hu; Tarek Hassanein; Thomas D Boyer; Lorene Kong; Wen-Pin Chen; Ellen Richmond; Rachel Gonzalez; Luz M Rodriguez; Frank L Meyskens
Journal:  Cancer Prev Res (Phila)       Date:  2015-06-30

Review 5.  Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.

Authors:  Man-Hsin Hung; Wei-Tien Tai; Chung-Wai Shiau; Kuen-Feng Chen
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

6.  Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.

Authors:  C-L Song; H Tang; L-K Ran; B C B Ko; Z-Z Zhang; X Chen; J-H Ren; N-N Tao; W-Y Li; A-L Huang; J Chen
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

7.  HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.

Authors:  Pinbo Huang; Qiaodong Xu; Yongcong Yan; Yingjuan Lu; Zhigang Hu; Bing Ou; Heyun Zhang; Kai Mao; Jianlong Zhang; Jie Wang; Zhiyu Xiao
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

8.  A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jie Peng; Jing Zhang; Qifan Zhang; Yikai Xu; Jie Zhou; Li Liu
Journal:  Diagn Interv Radiol       Date:  2018 May-Jun       Impact factor: 2.630

9.  Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.

Authors:  Lobna Mourad; Eman El-Ahwany; Mona Zoheiry; Hoda Abu-Taleb; Marwa Hassan; Amged Ouf; Ali Abdel Rahim; Moataz Hassanien; Suher Zada
Journal:  Cancer Biol Ther       Date:  2018-02-16       Impact factor: 4.742

10.  High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy.

Authors:  Qiujin Shen; Xin-Rong Yang; Yexiong Tan; Haiyan You; Yang Xu; Wei Chu; Tianxiang Ge; Jian Zhou; Shuang-Jian Qiu; Ying-Hong Shi; Zhigang Zhang; Jianren Gu; Hongyang Wang; Jia Fan; Wenxin Qin
Journal:  Hepat Oncol       Date:  2015-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.